Low-dose radiotherapy encourages the generation of IFN and improves the tumor immune microenvironment

Author:

Dong Jigang1,Li Baosheng2

Affiliation:

1. Qingdao People's Hospital Group (Jiaozhou),Qingdao Jiaozhou Central Hospital. Qingdao.266000. China,

2. Baosheng Li,Department of Radiotherapy.Shandong Cancer Hospital, Jinan,250000. China

Abstract

Abstract Background Radiation-induced apoptosis in tumor cells triggers signals such as phosphatidylserine and calreticulin to attract and activate dendritic cells, leading to T and NKT cell-based immune responses and macrophage phagocytosis. Objectives This study explored the potential of low-measure radiation to stimulate interferon (IFN) production, thereby enhancing immunogenic cell death in tumor cells. Methods Using a murine Lewis lung carcinoma model, mice underwent LDR (0.1 Gy every other day for five cycles), CTLA-4 treatment, or their combination. Flow cytometry, ELISA, immunohistochemistry, and RNA sequencing assessed immune cell infiltration, cytokine levels, and tumor growth dynamics. The role of IRF7 and IFN in LDR-mediated immune modulation was explored genetically and at the protein level. Results LDR enhanced IFN-α production, upregulated chemokines, and increased CD8 T cell infiltration in tumors. IRF7 emerged as a key mediator, with LDR promoting its expression, nuclear translocation, and heightened IFN production. Combining LDR with CTLA-4 synergistically suppressed tumor growth, increased CD8 T cell infiltration, and elevated IFN-γ levels. Conclusion LDR, through IRF7-mediated IFN induction, reshapes the tumor microenvironment, fostering anti-tumor immune responses. The synergy of LDR and CTLA-4 presents a potential strategy to address current cancer therapy challenges. This study contributes insights into LDR's immunomodulatory role, suggesting broader applications beyond cancer treatment.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3